Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PENUT Trial
NCT01378273Phase 3Completed
- Sponsor
- University of Washington
- Start
- Dec 2013
- Primary completion
- Feb 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of erythropoietin in Extreme prematurity (EP), sponsored by University of Washington. Started Dec 2013; status: completed.
02
Drugs
erythropoietin
03
Conditions
Extreme prematurity (EP)
Beyond the preview
Go deeper on NCT01378273.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01378273.